Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study

Elizabeth H Phillips; Michelle M Lannon; Andre Lopes; Humra Chadwick; Gail Jones; Michal Sieniawski; Andrew Davies; Katrina Wood; Laura Clifton-Hadley; Paul Smith; Anthony Lawrie; Nick Chadwick; Anne L Lennard

doi:10.1038/s41409-019-0504-6

Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study

Bone Marrow Transplant. 2020 Apr;55(4):840. doi: 10.1038/s41409-019-0504-6.

Affiliations

¹ Cancer Research UK and University College London Cancer Trials Centre, London, UK. b.phillips@ucl.ac.uk.
² Department of Haematology, Freeman Hospital, Newcastle Upon Tyne, UK.
³ Cancer Research UK and University College London Cancer Trials Centre, London, UK.
⁴ South Tyneside District Hospital, South Shields, UK.
⁵ Cancer Research UK Centre, Cancer Sciences Unit, University of Southampton, Faculty of Medicine, Southampton, UK.
⁶ Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.

PMID: 30862820
DOI: 10.1038/s41409-019-0504-6

Abstract

In the original version of this article, the mention of 'ifosfamide 1500 mg/m² days 1-3' should, in fact, read 'ifosfamide 1500 mg/m² bd days 1-3'. This has now been updated in the original version of the article.

Publication types

Published Erratum